Your browser doesn't support javascript.
loading
Bismuth, esomeprazole, metronidazole and amoxicillin or tetracycline as a first-line regimen for Helicobacter pylori eradication: A randomized controlled trial.
Tian, Xue-Li; Suo, Bao-Jun; Zhang, Hua; Lu, Hao-Ping; Li, Cai-Ling; Zhang, Yu-Xin; Ren, Xin-Lu; Yao, Xing-Yu; Zhou, Li-Ya; Song, Zhi-Qiang.
Afiliación
  • Tian XL; Department of Gastroenterology, Peking University Third Hospital, Beijing, China.
  • Suo BJ; Department of Gastroenterology, Peking University Third Hospital, Beijing, China.
  • Zhang H; Research Center of Clinical Epidemiology, Peking University Third Hospital, Beijing, China.
  • Lu HP; Department of Gastroenterology, Peking University Third Hospital, Beijing, China.
  • Li CL; Department of Gastroenterology, Peking University Third Hospital, Beijing, China.
  • Zhang YX; Department of Gastroenterology, Peking University Third Hospital, Beijing, China.
  • Ren XL; Department of Gastroenterology, Peking University Third Hospital, Beijing, China.
  • Yao XY; Department of Gastroenterology, Peking University Third Hospital, Beijing, China.
  • Zhou LY; Department of Gastroenterology, Peking University Third Hospital, Beijing, China.
  • Song ZQ; Department of Gastroenterology, Peking University Third Hospital, Beijing, China.
Helicobacter ; 28(1): e12935, 2023 Feb.
Article en En | MEDLINE | ID: mdl-36374159
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Helicobacter pylori / Infecciones por Helicobacter Tipo de estudio: Clinical_trials / Guideline Límite: Humans Idioma: En Revista: Helicobacter Asunto de la revista: BACTERIOLOGIA Año: 2023 Tipo del documento: Article País de afiliación: China Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Helicobacter pylori / Infecciones por Helicobacter Tipo de estudio: Clinical_trials / Guideline Límite: Humans Idioma: En Revista: Helicobacter Asunto de la revista: BACTERIOLOGIA Año: 2023 Tipo del documento: Article País de afiliación: China Pais de publicación: Reino Unido